chitosan has been researched along with dactolisib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Che, Y; Chen, Y; Li, X; Shen, X; Shi, F; Wang, Z; Wu, Q; Xie, X; Xing, K; Yuan, S; Zhong, X; Zhu, Q | 1 |
1 other study(ies) available for chitosan and dactolisib
| Article | Year |
|---|---|
Chitosan nanoparticles encapsulated with BEZ235 prevent acute rejection in mouse heart transplantation.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Chitosan; Heart Transplantation; Mice; Nanoparticles; Phosphoinositide-3 Kinase Inhibitors; Quinolines; TOR Serine-Threonine Kinases | 2023 |